Bristol-Myers Sued Over Heart Damage In Hep C Drug Trial

Law360, New York (August 27, 2012, 6:08 PM EDT) -- A Texas woman who says she needs a heart transplant after taking an experimental hepatitis C drug developed by Bristol-Myers Squibb Co. sued the drugmaker on Friday, the same day the company announced it’s taking a $1.8 billion charge on the discontinued treatment.

Janet Schaefer Vella claims she started the medicine, known as BMS-986094, during a clinical trial in early July and after one week underwent a diagnostic test that indicated possible heart malfunction. Vella says she was told to keep taking the drug and had...
To view the full article, register now.